Borgogno, Marta
Davico, Chiara
Vitiello, Benedetto
Martinuzzi, Andrea
Ricci, Federica Silvia
Amianto, Federico
Marcotulli, Daniele
Article History
Received: 14 September 2025
Accepted: 6 February 2026
First Online: 3 March 2026
Declarations
Ethics approval and consent to participate: The study was approved by the Ethics Committee of the University of Turin (protocol no. 0565208 of 27/9/2024) and designed in accordance with the principles of the Declaration of Helsinki of the World Medical Association. Students and their parents were provided with written explanations of the background, purpose and aims of the study. All parents signed a written informed consent, and all minors gave their assent to participate.
Competing interests: In the last 2 years, BV has received consultant fees or honoraria from Medice, Menarini, Angelini (Ethos), and Alkermes Pharmaceuticals.